Barclays Hikes Atlassian Price Target to $112: Annual Recurring Revenue Disclosure Validates the Enterprise Bull Case

Photo of David Moadel
By David Moadel Published
Barclays Hikes Atlassian Price Target to $112: Annual Recurring Revenue Disclosure Validates the Enterprise Bull Case

© Ground Picture / Shutterstock.com

Barclays raised its price target on Atlassian (NASDAQ:TEAM | TEAM Price Prediction) stock to $112 from $106 while keeping an Overweight rating, declaring that the company’s new annual recurring revenue (ARR) disclosure validates the improving trajectory of its growth algorithm. The price target raise follows Atlassian’s investor forum, where management spotlighted clear enterprise momentum behind the Jira and Confluence maker. For long-term investors, the analyst upgrade signals deepening Wall Street confidence in the firm’s enterprise pivot.

Atlassian stock has rallied sharply since last week’s Q3 FY2026 results, climbing 26% over the past week to $90.99. Shares still sit far below the 52-week high of $232.36, framing the Barclays note as a recovery thesis rather than a momentum chase. For broader context on software sector positioning, see our recent coverage of top software stocks.

Ticker Company Firm Action Old Rating New Rating Old Target New Target
TEAM Atlassian Barclays Price Target Raise Overweight Overweight $106 $112

The Analyst’s Case

For a SaaS business, ARR is often the cleanest forward-looking growth indicator because it strips out revenue-recognition noise and reflects the run-rate value of the customer base. By choosing to disclose its ARR, Atlassian is inviting the market to measure it on a metric where the trajectory is accelerating.

The supporting data is concrete. Atlassian’s Service Collection eclipsed $1 billion in ARR, growing over 30% year-over-year, with enterprise ARR inside that collection growing over 50%. CEO Mike Cannon-Brookes asserted that the milestone “continues to take share and reinforce our conviction in the long-term growth opportunity of the Atlassian System of Work.”

Company Snapshot

Atlassian builds enterprise collaboration software including Jira, Confluence, Jira Service Management, Rovo, Loom, Bitbucket, and Trello, serving 85% of the Fortune 500. The aggressive sunset of server-deployed software pushed customers toward cloud, creating near-term revenue noise but cleaner long-term economics.

Atlassian’s Q3 FY2026 revenue reached $1.79 billion, up 32% year over year, with remaining performance obligations of $4 billion, up 37%. The customer mix now includes more than 600 customers contributing $1 million-plus in ARR.

Why the Move Matters Now

Atlassian’s valuation looks more reasonable than it did a year ago, with TEAM stock trading at a forward P/E ratio of 17x and price-to-sales of 4x. Management is also returning capital aggressively, repurchasing 11.8 million shares for $1 billion in Q3, with $2.2 billion remaining on the buyback authorization.

Enterprise momentum is the second pillar for Atlassian. Larger contract values, longer terms, and stickier relationships are showing up in net revenue retention (NRR) maintained north of 120% and competitive displacements from legacy IT service management (ITSM) rivals like ServiceNow at record levels.

What It Means for Your Portfolio

The bull case for Atlassian stock rests on platform breadth, AI-driven seat expansion, and enterprise wallet share. Rovo customers are growing ARR at roughly 2x the rate of non-Rovo customers, with AI credit usage growing 20%-plus month over month.

The bear case is real: rich valuation versus GAAP losses, AI-driven workflow disruption risk, and competitive intensity from Microsoft, GitLab, Asana, and Monday.com. Atlassian also flagged that Data Center revenue growth will meaningfully decelerate in FY27 as the end-of-life recognition tailwind laps.

Prudent investors weighing TEAM stock might consider a measured position size. The Barclays price target raise validates the enterprise thesis, yet the multi-year journey through cloud migration and stock-based compensation debates argues for patience over conviction sizing.

Photo of David Moadel
About the Author David Moadel →

David Moadel is financial writer specializing in stocks, ETFs, options, precious metals, and Bitcoin. David has written well over 1,000 articles for leading online publications, helping investors understand markets, income strategies, and risk.

His work has appeared in The Motley Fool, InvestorPlace, U.S. News & World Report, TipRanks, ValueWalk, Benzinga, Market Realist, TalkMarkets, Finmasters, 24/7 Wall St., and others.

With a master’s degree in education, David has taught at the elementary, high school, and college levels. That teaching background shapes his writing style: clear, educational, and practical. David has also built a loyal social-media audience by providing trustworthy financial content on YouTube, X/Twitter, and StockTwits.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

KMX Vol: 7,330,419
GLW Vol: 22,800,969
INTC Vol: 233,719,006
SMCI Vol: 68,465,534
ENPH Vol: 13,978,376

Top Losing Stocks

ACN Vol: 41,744,333
EPAM Vol: 5,636,587
CTSH Vol: 61,311,400
CTRA Vol: 73,319,495
KR Vol: 26,704,230